To review the evidence and provide recommendations on screening for and management of bacterial vaginosis in pregnancy.
The clinical practice options considered in formulating the guideline.
Outcomes evaluated include antibiotic treatment efficacy and cure rates, and the influence of the treatment of bacterial vaginosis on the rates of adverse pregnancy outcomes such as preterm labour and delivery and preterm premature rupture of membranes.
Medline, EMBASE, CINAHL, and Cochrane databases were searched for articles, published in English before the end of June 2007 on the topic of bacterial vaginosis in pregnancy.
The evidence obtained was rated using the criteria developed by the Canadian Task Force on Preventive Health Care.
Guideline implementation will assist the practitioner in developing an approach to the diagnosis and treatment of bacterial vaginosis in pregnant women. Patients will benefit from appropriate management of this condition.
These guidelines have been prepared by the Infectious Diseases Committee of the SOGC, and approved by the Executive and Council of the SOGC.
The Society of Obstetricians and Gynaecologists of Canada.
To determine whether providing an information pamphlet in the antenatal clinic improves women's knowledge about influenza and vaccine recommendations during pregnancy.
An information pamphlet was distributed in the antenatal clinic during the fall of 2007. A cross-sectional survey was carried out in women on the postpartum floor in the fall of 2006 and again in the fall of 2007 (before and after implementation of the pamphlet) to assess women's knowledge. Results were compared to assess knowledge transfer.
Knowledge improved with the use of the educational pamphlet. Most women in both years (>90%) correctly answered that influenza is a serious infection. However, significantly more women in 2007 correctly answered that pregnant women have a higher risk of complications from influenza (34.6% in 2007 vs. 12.1% in 2006, P
We wished to assess pregnant women's knowledge of influenza, vaccine safety during pregnancy and breast feeding, and the recommendations for use of the influenza vaccine in pregnancy.
We performed a cross-sectional survey of postpartum women during influenza season in 2006.
Pregnant women's overall knowledge of these subjects was poor. Most women (95%) knew that influenza is highly contagious, but almost 90% incorrectly believed that pregnant women have the same risk of complications as non-pregnant women. Only one half of the women were aware of national recommendations for vaccination during pregnancy and that the vaccine is safe during pregnancy and breast feeding, and 80% incorrectly believed that the vaccine can cause birth defects. Only 20% of women had been offered the vaccine during the current pregnancy or a prior pregnancy.
Pregnant women's knowledge about influenza vaccine recommendations and safety during pregnancy is poor. There is substantial room for improvement among prenatal care providers in both patient education and offering the vaccine.
West Nile virus (WNV) is an emerging infection that can lead to substantial morbidity and mortality. Although data are limited with respect to the risk to the fetus and neonate, this risk is not inconsequential. Methods to reduce the risk of mosquito bites and WNV transmission are simple, economical, and effective in the non-pregnant population. The objective of this descriptive cross-sectional study was to assess adherence to protective behaviours against WNV in pregnant women and to determine predictors for such adherence.
A questionnaire was administered to all consenting pregnant women at two Toronto university hospitals.
The majority of women reported practising behaviours that reduce the risk of mosquito bites and potentially of WNV infection. In this survey, between 40% and 80% of pregnant women avoided the outdoors, avoided areas with mosquitoes, and reported practising two or more personal protection behaviours. However, only 33% of pregnant women reported wearing mosquito repellent, with the majority expressing concern about the safety of repellent use during pregnancy. The majority of pregnant women cited the media or the Internet as a source of their knowledge about WNV; only 12% reported their physician as a source of such knowledge.
The majority of pregnant women are aware of WNV and practise protective behaviours that reduce the risk of transmission. However, they have unjustified fetal safety concerns about the use of mosquito repellent and are thus less likely to use it.
To determine whether ethnicity affects awareness, knowledge, and attitudes regarding the human papillomavirus (HPV) and the HPV vaccine.
English speaking women (n = 172) aged 18 and older were recruited from an outpatient gynaecology clinic to complete a self-administered cross-sectional questionnaire that gathered information about (1) virus awareness and knowledge, (2) vaccine awareness and knowledge, (3) attitudes towards the vaccine and (4) participant demographics. Subjects received a virus knowledge score (0 to 6), a vaccine knowledge score (0 to 10) and an attitudes score (8 to 40), with a higher score indicating more positive attitudes towards the vaccine.
Virus and vaccine awareness was significantly higher in Caucasian respondents than in non-Caucasian respondents: 93% versus 69% (P
Women who are refugees during pregnancy may be exposed to homelessness, poor nutrition, and limited access to health care, yet the pregnancy outcomes of this vulnerable population have not been systematically evaluated. We undertook a study to determine the risk of adverse obstetric and perinatal outcomes among refugee women in Toronto.
Using a retrospective cohort design, we examined pregnancy outcomes for refugee and non-refugee women delivering at St. Michael's Hospital in Toronto, between January 1, 2008, and December 31, 2010. The primary outcome measures were preterm delivery (
To evaluate whether the length of time of rupture of membranes (ROM) in optimally managed HIV-positive women on highly active antiretroviral therapy (HAART) with low viral loads (VL) is predictive of the risk of mother to child transmission (MTCT) of the human immunodeficiency virus (HIV).
A retrospective case series of all HIV-positive women who delivered at two academic tertiary centers in Toronto, Canada from January 2000 to November 2010 was completed.
Two hundred and ten HIV-positive women with viral loads
Cites: Int J Gynaecol Obstet. 1999 Sep;66(3):305-610580685
Cites: Int J Gynaecol Obstet. 2003 Jul;82(1):17-2312834937
Cites: Am J Obstet Gynecol. 1995 Aug;173(2):585-97645638
Cites: N Engl J Med. 1996 Jun 20;334(25):1617-238628356
Cites: JAMA. 1998 Jul 1;280(1):55-609660364
Cites: N Engl J Med. 1999 Apr 1;340(13):977-8710099139
Cites: HIV Med. 2011 Apr;12(4):228-3520726902
Cites: Clin Infect Dis. 2005 Feb 1;40(3):458-6515668871